Sickle Cell Disease Clinical Trial Patient Recruitment

Sickle cell disease patient recruitment for HbSS, HbSC, and gene therapy clinical trials.

Who qualifies: Patients with SCD (HbSS, HbSC, HbSβ⁰-thalassemia) aged 12+ with history of vaso-occlusive crises.

Recruitment challenges: Hemoglobin genotype confirmation and prior hydroxyurea treatment eligibility.

Our approach: Sickle cell disease center networks, patient advocacy partnerships, and genotype pre-screening.